These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36380821)

  • 1. Blood and Blood Product Conservation: Results of Strategies to Improve Clinical Outcomes in Open Heart Surgery Patients at a Tertiary Hospital Are Maintained 4 Years after Initiation.
    Khan JH; Barkin MS; Stanton J; Khan A; Stanten RD
    J Extra Corpor Technol; 2022 Mar; 54(1):35-41. PubMed ID: 36380821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood and Blood Product Conservation: Results of Strategies to Improve Clinical Outcomes in Open Heart Surgery Patients at a Tertiary Hospital.
    Khan JH; Green EA; Chang J; Ayala AM; Barkin MS; Reinys EE; Stanton J; Stanten RD
    J Extra Corpor Technol; 2017 Dec; 49(4):273-282. PubMed ID: 29302118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less is more: We are administering too much protamine in cardiac surgery.
    De Simone F; Nardelli P; Licheri M; Frau G; Redaelli MB; Monaco F; Zangrillo A; Landoni G
    Ann Card Anaesth; 2021; 24(2):178-182. PubMed ID: 33884973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of Protamine Titration-Based Heparin Neutralization in Patients Undergoing Coronary Bypass Grafting Surgery.
    Abuelkasem E; Mazzeffi MA; Henderson RA; Wipfli C; Monroe A; Strauss ER; Chow JH; Tanaka KA
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2153-2160. PubMed ID: 30737123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protamine dosing and its impact in cardiac surgery transfusion practice-A retrospective bi-institutional analysis.
    Mondal S; Abuelkasem E; Vesselinov R; Henderson R; Choi S; Mousa A; Zaza KJ; Tanaka KA
    Transfusion; 2024 Mar; 64(3):467-474. PubMed ID: 38264767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery.
    Deptula J; Glogowski K; Merrigan K; Hanson K; Felix D; Hammel J; Duncan K
    J Extra Corpor Technol; 2006 Mar; 38(1):22-6. PubMed ID: 16637519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A change in anticoagulation monitoring improves safety, reduces transfusion, and reduces costs in infants on cardiopulmonary bypass.
    Machovec KA; Jooste EH; Walczak RJ; Homi HM; Jaquiss RD; Lodge AJ; Ames WA
    Paediatr Anaesth; 2015 Jun; 25(6):580-6. PubMed ID: 25530420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
    Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
    Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot validation of an individualised pharmacokinetic algorithm for protamine dosing after systemic heparinisation for cardiopulmonary bypass.
    Miles LF; Marchiori P; Falter F
    Perfusion; 2017 Sep; 32(6):481-488. PubMed ID: 28820026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the Minimum Protamine Dose to Neutralize Heparin at the Completion of Cardiopulmonary Bypass be Significantly Lower than the Conventional Practice?
    Lee MH; Riley W; Shann KG
    J Extra Corpor Technol; 2021 Sep; 53(3):170-176. PubMed ID: 34658407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of postoperative heparin rebound following cardiopulmonary bypass.
    Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
    Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S
    Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery.
    DeLaria GA; Tyner JJ; Hayes CL; Armstrong BW
    Arch Surg; 1994 Sep; 129(9):944-50; discussion 950-1. PubMed ID: 8080377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate predictors of blood product use in cardiac surgery.
    Parr KG; Patel MA; Dekker R; Levin R; Glynn R; Avorn J; Morse DS
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):176-81. PubMed ID: 12698398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy.
    Hofmann B; Bushnaq H; Kraus FB; Raspé C; Simm A; Silber RE; Ludwig-Kraus B
    Perfusion; 2013 Sep; 28(5):412-8. PubMed ID: 23625867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
    Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F
    PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 0.6-protamine/heparin ratio in cardiac surgery is associated with decreased transfusion of blood products.
    Goedhart ALM; Gerritse BM; Rettig TCD; van Geldorp MWA; Bramer S; van der Meer NJM; Boonman-de Winter LJ; Scohy TV
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):391-397. PubMed ID: 32620960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.